Articles published by Merck & Co., Inc.
Merck Announces Clinical Holds on Studies Evaluating Islatravir for the Treatment and Prevention of HIV-1 Infection
December 13, 2021
From Merck & Co., Inc.
Via Business Wire
Tickers
MRK
Merck Issues $1 Billion Inaugural Sustainability Bond
December 13, 2021
From Merck & Co., Inc.
Via Business Wire
Tickers
MRK
Merck Prices $8.0 Billion Debt Offering
December 07, 2021
From Merck & Co., Inc.
Via Business Wire
Tickers
MRK
Merck Announces Additional $150M Investment Through 2025 to Help End Maternal Mortality Inequities
December 07, 2021
From Merck & Co., Inc.
Via Business Wire
Tickers
MRK
Merck Announces First-Quarter 2022 Dividend
November 30, 2021
From Merck & Co., Inc.
Via Business Wire
Tickers
MRK
Merck to Present at the 4th Annual Evercore ISI HealthCONx Conference
November 24, 2021
From Merck & Co., Inc.
Via Business Wire
Tickers
MRK
Merck Completes Acquisition of Acceleron Pharma Inc.
November 22, 2021
From Merck & Co., Inc.
Via Business Wire
Tickers
MRK
Merck Completes Tender Offer to Acquire Acceleron Pharma Inc.
November 19, 2021
From Merck & Co., Inc.
Via Business Wire
Tickers
MRK
Merck and Ridgeback’s Molnupiravir, an Oral COVID-19 Antiviral Medicine, Receives First Authorization in the World
November 04, 2021
From Merck & Co., Inc.
Via Business Wire
Tickers
MRK
Merck Announces Third-Quarter 2021 Financial Results
October 28, 2021
From Merck & Co., Inc.
Via Business Wire
Tickers
MRK
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.